Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GC4419 for Oral Mucositis in Head and Neck Cancer
NCT04529850Phase 2Completed
- Sponsor
- Galera Therapeutics, Inc.
- Start
- Jun 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of avasopasem manganese in oral mucositis (OM), sponsored by Galera Therapeutics, Inc.. Started Jun 2020; status: completed.
02
Drugs
avasopasem manganese
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT04529850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04529850.